Exelixis collaborates with Merck KGaA and Pfizer to evaluate XL-092 plus avelumab in UC March 19, 2021
Clinical trial collaboration supports new phase II study of Tabrecta and Nerlynx in breast cancer March 17, 2021
In vitro and in vivo evaluation of quinazolinone derivative HoLu-12 for oral squamous cell carcinoma March 16, 2021
RSS